Detalhe da pesquisa
1.
UM171 suppresses breast cancer progression by inducing KLF2.
Breast Cancer Res Treat
; 2024 Jun 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38874684
2.
FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.
BMC Cancer
; 24(1): 326, 2024 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38461240
3.
Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling.
BMC Cancer
; 23(1): 306, 2023 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37016335
4.
Current insights into the role of Fli-1 in hematopoiesis and malignant transformation.
Cell Mol Life Sci
; 79(3): 163, 2022 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35412146
5.
A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9.
Int J Mol Sci
; 23(18)2022 Sep 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36142828
6.
ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes.
BMC Cancer
; 21(1): 680, 2021 Jun 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34107900
7.
Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.
Adv Exp Med Biol
; 1223: 17-30, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32030683
8.
Fli-1 Activation through Targeted Promoter Activity Regulation Using a Novel 3', 5'-diprenylated Chalcone Inhibits Growth and Metastasis of Prostate Cancer Cells.
Int J Mol Sci
; 21(6)2020 Mar 23.
Artigo
Inglês
| MEDLINE | ID: mdl-32210104
9.
A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Breast Cancer Res
; 21(1): 18, 2019 01 31.
Artigo
Inglês
| MEDLINE | ID: mdl-30704524
10.
Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.
BMC Cancer
; 19(1): 764, 2019 Aug 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31375085
11.
Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer.
Bioorg Med Chem
; 26(23-24): 6096-6104, 2018 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30471828
12.
Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A.
Blood
; 126(6): 766-78, 2015 Aug 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26041742
13.
The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.
Blood
; 119(19): 4486-98, 2012 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-22451425
14.
An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.
Mol Med Rep
; 29(6)2024 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38695236
15.
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.
Cancer Cell
; 7(1): 101-11, 2005 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-15652753
16.
CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer.
Oncogenesis
; 12(1): 29, 2023 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37230983
17.
FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression.
J Inflamm Res
; 16: 2007-2020, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37193069
18.
Thinking (Metastasis) outside the (Primary Tumor) Box.
Cancers (Basel)
; 15(22)2023 Nov 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38001575
19.
Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.
Nat Commun
; 14(1): 4313, 2023 07 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37463901
20.
The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis.
Blood
; 116(3): 428-36, 2010 Jul 22.
Artigo
Inglês
| MEDLINE | ID: mdl-20445019